#LBS25 to Spotlight Advancements in Pharmaceutical Biotechnology, Digital Health, Medical Devices, Advanced Therapies, and More

London, December 10: The second edition of the London Biotechnology Show (#LBS) continues to elevate its prestige with each passing day, as more renowned speakers and leading exhibitors join the lineup, solidifying its position as a premier platform for addressing the biotech sector's most critical challenges and groundbreaking opportunities.

The conference agenda is packed with thought-provoking keynote speeches, interactive discussions, and panel sessions. Attendees will gain insights into groundbreaking topics such as gene editing, regenerative medicine, pharmaceuticals, bioinformatics, medical devices , biomedical engineering, biotechnology in agriculture, and the latest in digital health. This year’s program not only delves into emerging trends but also provides actionable strategies for professionals shaping the future of biotechnology.

Ready to deliver on these crucial topics, the conference features an exceptional lineup, including representatives from leading organizations such as Google, Novo Nordisk, Microsoft, Bayer Pharmaceuticals, the Medicines and Healthcare products Regulatory Agency, Genomics England, and AstraZeneca. Notable participants include:

• Andrew Miles - Multicultural Executive & Leader in Life Sciences and Technology - Google
• Dr. Bryn Roberts - Global Head of Data, Analytics & Research - Roche Information Solutions
• Thomas Balkizas - Senior Director Life Sciences - Microsoft
• Dr. Nicole Mather - Health & Life Sciences Leader - IBM
• Professor Sir Mark Caulfield - Vice Principal for Health, Faculty of Medicine and Dentistry - Queen Mary University of London
• Sadegh Mohammadi - Head of Computer Vision and Sound Analysis - Bayer Pharmaceuticals
• Mark Davies - Chief Health Officer - IBM
• Professor Andrew M. Wardley - Executive Chair - The Association of Cancer Physicians Royal College of Physicians
• Georgina Rizik - Chief Executive Officer - SC1 London Life Sciences Innovation District
• Dr. James Duboff - Strategic Partnerships Director - Genomics England
• Click to Check the Entire List of Speakers.

In addition to an enriching conference, #LBS25 hosts an impressive exhibition, featuring leading biotech organisations, innovators and solution providers. Discovery Park leads as the Gold Sponsor, setting a benchmark for excellence. Silver Sponsors include Haier Biomedical UK Ltd, Ellab, and Mathys & Squire, while Bronze Sponsors such as Cool Repair System, Homogenising Systems Ltd, and Merck further elevate the event’s stature.

The exhibition floor will also spotlight innovative companies such as Stratagem IPM, LI-Cor Bioscience Ltd, Restore Harrow Green, NIHR, FORMULATRIX, Clarity Compliance Solutions, Brookhouse, BRAND Scientific, Synbiosis, LAUDA Technology, Carterra, ProteoGenix, Life4sciences, Adelphi Healthcare Packaging, IKA, Appleton Woods, Firefinch Software, Integra Biosciences, Exeter Science Park, Miltenyi Biotec, Sterilem Bioscience, Eppendorf, Bishop Simon, LS Scientific, Guardtech Group, Orion GXP Consulting, Fieldfare Consulting, Oxartis, All Med Pro, and INDICRO, highlighting promising ventures with the potential to drive future biotech breakthroughs. Link to the entire list of exhibitors.

Recognising the power of collaboration, #LBS25’s has added a Hosted Buyer Programme offering attendees and participants a unique opportunity to connect with sponsors and exhibitors through pre-arranged, one-on-one meetings. This tailored matchmaking approach enables biotech professionals to expand their networks, discover complementary solutions, and establish valuable partnerships.

Don’t miss out on this extraordinary opportunity to witness the forefront of biotech innovation. Register now to secure your place at #LBS25 and connect with the industry's most influential leaders.

For more information, please contact: press@valiantandcompany.com